AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Viatris Reports Positive Top-line Results From LYNX-2 Phase 3 Trial With MR-142
(RTTNews) - Viatris (VTRS) reported positive top-line results from LYNX-2, a Phase 3 trial evaluating MR-142 in treating significant, chronic night driving impairment in keratorefractive patients with...
- June 02, 2025 05:19 AM PDT
- EODHD
Non-contributory Pension Plan: Employer-Funded Retirement Benefit
Highlights,Fully funded by the employer without requiring employee contributions,Provides retirement benefits solely supported by the company’s payments,Offers employees a retirement plan with no direct financial obligation,A non-contributory pension plan...
- June 02, 2025 05:15 AM PDT
- Team Kalkine Media
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior...
- June 02, 2025 05:10 AM PDT
- EODHD
Kymera Therapeutics soars 35% on positive phase 1 results for oral STAT6 degrader KT-621
[Doctors talking to MRI technicians about Magnetic Resonance Images MRI] Willie B. Thomas Kymera Therapeutics (NASDAQ:KYMR [https://seekingalpha.com/symbol/KYMR]) Monday reported [https://seekingalpha...
- June 02, 2025 05:09 AM PDT
- EODHD
Joint Press Release of Constellation Software Inc. and Topicus.com Inc. -- Topicus.com Inc. completes acquisition of Cipal Schaubroeck in Belgium
Constellation Software Inc. TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX: CSU) and Topicus.com Inc. (TSXV: TOI) today announced that Topicus’ subsidiary Total Specific S...
- June 02, 2025 05:04 AM PDT
- EODHD
Xilio Therapeutics announces public offering; shares down
* Xilio Therapeutics (NASDAQ:XLO [https://seekingalpha.com/symbol/XLO]) announced an underwritten public offering of pre-funded warrants and Series A, B, and C warrants to purchase shares of common st...
- June 02, 2025 05:02 AM PDT
- EODHD
How AstraZeneca Is Playing Its Cancer Cards To Become An $80 Billion Pharma
Three new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030. Continue Reading View Comments
- June 02, 2025 05:00 AM PDT
- EODHD
UPS Appoints John Morikis to Board of Directors
ATLANTA, June 02, 2025--(BUSINESS WIRE)--UPS (NYSE: UPS) today announced the appointment of John Morikis to the UPS Board of Directors, effective immediately. Morikis is the retired Chairman, Presiden...
- June 02, 2025 05:00 AM PDT
- EODHD
Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
CONSHOHOCKEN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46th Annual Global Goldman Sachs Health Care...
- June 02, 2025 05:00 AM PDT
- EODHD
Market Chatter: Alphabet, Amazon-Backed Anthropic Hits $3 Billion Annualized Revenue as Demand for AI Services Surges
Alphabet (GOOGL) and Amazon (AMZN) backed Artificial intelligence developer Anthropic has reached $3 PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscripti...
- June 02, 2025 04:51 AM PDT
- EODHD